Pneumothorax during lenvatinib plus pembrolizumab for recurrent endometrial cancer: A case report
Objective: Pneumothorax is a rare adverse event in cancer treatment. Lenvatinib, a multi-kinase inhibitor with antiangiogenic activity, may cause organ perforation. We present a case of pneumothorax during lenvatinib plus pembrolizumab (LP) therapy for endometrial cancer. Case report: A 63-year-old...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-09-01
|
| Col·lecció: | Taiwanese Journal of Obstetrics & Gynecology |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1028455925001895 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|